ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC50160-10mg |
|
51987-99-6 |
TGN 020
|
0 | — | |
GC50159-50mg |
|
37710-81-9 |
TC AQP1 1
|
0 | — | |
GC50159-10mg |
|
37710-81-9 |
TC AQP1 1
|
0 | — | |
GC50158-50mg |
|
1373154-68-7 |
GA3-AM
|
0 | — | |
GC50158-10mg |
|
1373154-68-7 |
GA3-AM
|
0 | — | |
GC50157-500μg |
|
1417537-93-9 |
6bK
|
0 | — | |
GC50156-5mg |
|
1246030-96-5 |
GSK 2250665A
|
0 | — | |
GC50155-50mg |
|
1415264-56-0 |
Virodhamine trifluoroacetate
|
0 | — | |
GC50155-10mg |
|
1415264-56-0 |
Virodhamine trifluoroacetate
|
0 | — | |
GC50154-50mg |
|
1443748-47-7 |
VU 0469650 hydrochloride
|
0 | — | |
GC50154-10mg |
|
1443748-47-7 |
VU 0469650 hydrochloride
|
0 | — | |
GC50153-50mg |
|
101714-41-4 |
BIX
|
0 | — | |
GC50153-10mg |
|
101714-41-4 |
BIX
|
0 | — | |
GC50152-1mg |
|
334994-34-2 |
Norleual
|
0 | — | |
GC50151-50mg |
|
1269802-97-2 |
NHI 2
|
0 | — | |
GC50151-10mg |
|
1269802-97-2 |
NHI 2
|
0 | — | |
GC50150-50mg |
|
1431980-60-7 |
TASP 0433864
|
0 | — | |
GC50150-10mg |
|
1431980-60-7 |
TASP 0433864
|
0 | — | |
GC50149-50mg |
|
910045-32-8 |
PQ 69
|
0 | — | |
GC50149-10mg |
|
910045-32-8 |
PQ 69
|
0 | — | |